Molecular characterization and antimicrobial susceptibility for 62 isolates of from children.

Baohua He, Zhaoyi Jia, Fei Zheng, Wenchao Zhang, Suxia Duan, Leyu Wang, Haixia Zhang, Hongbin Zhang, Ruoxuan Wang, Yuan Gao, Yinqi Sun
Author Information
  1. Baohua He: Hebei Key Laboratory of Pathogens and Epidemiology of Infectious Diseases, HeBei Provincial Center for Disease Control and Prevention, Shijiazhuang, China.
  2. Zhaoyi Jia: Hebei Key Laboratory of Pathogens and Epidemiology of Infectious Diseases, HeBei Provincial Center for Disease Control and Prevention, Shijiazhuang, China.
  3. Fei Zheng: School of Public Health, North China University of Science and Technology, Tangshan, China.
  4. Wenchao Zhang: Hebei Children's Hospital, Shijiazhuang, China.
  5. Suxia Duan: Hebei Children's Hospital, Shijiazhuang, China.
  6. Leyu Wang: Hebei Key Laboratory of Pathogens and Epidemiology of Infectious Diseases, HeBei Provincial Center for Disease Control and Prevention, Shijiazhuang, China.
  7. Haixia Zhang: Hebei Key Laboratory of Pathogens and Epidemiology of Infectious Diseases, HeBei Provincial Center for Disease Control and Prevention, Shijiazhuang, China.
  8. Hongbin Zhang: Hebei Key Laboratory of Pathogens and Epidemiology of Infectious Diseases, HeBei Provincial Center for Disease Control and Prevention, Shijiazhuang, China.
  9. Ruoxuan Wang: School of Public Health, North China University of Science and Technology, Tangshan, China.
  10. Yuan Gao: National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
  11. Yinqi Sun: Hebei Key Laboratory of Pathogens and Epidemiology of Infectious Diseases, HeBei Provincial Center for Disease Control and Prevention, Shijiazhuang, China.

Abstract

Background: Pertussis is a highly contagious respiratory disease caused by (BP). Despite global control of pertussis cases through the Expanded Programme on Immunization (EPI), there has been a significant increase in the incidence of pertussis in recent years, characterized by a "resurgence" in developed countries with high immunization rates as well as a comparable reemergence in certain areas of China. We aim to explore the genotypes and antimicrobial susceptibility of circulating BP from children in Hebei.
Study design: Children diagnosed with BP infection from 2019 to 2020 in Hebei, China were enrolled. We performed antimicrobial susceptibility testing (AST), whole-genome sequencing (WGS) analysis, single nucleotide polymorphism (SNP) detection, mltilocus sequence typing (MLST), multilocus antigen sequence typing (MAST), multilevel genome typing (MGT). A total of 313 international BP genomes were selected for comparison to examine the genomic diversity and evolutionary traits of Chinese strains within a global framework.
Results: Sixty-two individuals were identified with BP infection via culture, yielding a positive rate of 15.62% (62/397) for BP. Two phylogenetic groups were identified, each carrying a dominating genotype. The two vaccine strains, CS and Tohama I, exhibited a distant relationship to these two groups. This study identified 56 erythromycin-resistant isolates, 55 azithromycin-resistant isolates, 58 sulfamethoxazole-sensitive isolates, and 53 cefotaxime-sensitive isolates. All BP isolates were sensitive to levofloxacin, amoxicillin, ceftriaxone, and meropenem. Meanwhile, all erythromycin-resistant strains, which belonged to lineage I and MGT2 sequence type 7 (ST7), shared the gene and contained the 23S rRNA A2047G mutation. The major MAST was //// (75.81%). All 62 BP strains were divided into 1, 2, 3, 14, and 52 types at the MGT1, MGT2, MGT3, MGT4, and MGT5 levels, respectively.
Conclusion: This work showed that there may be a link between antimicrobial resistance and alterations in specific molecular types, and the isolates showed a clear change when compared with the vaccine strain and that selection pressure from both antibiotics and immunization may be responsible for driving Chinese BP evolution, and necessitate a reevaluation of the immunization strategy and the development of novel vaccines in China to halt the resurgence and medication resistance of pertussis.

Keywords

References

  1. Mol Biol Evol. 2023 Nov 3;40(11): [PMID: 37948764]
  2. Clin Infect Dis. 2015 Sep 15;61(6):1028-9 [PMID: 26060284]
  3. Bioinformatics. 2014 Aug 1;30(15):2114-20 [PMID: 24695404]
  4. Emerg Microbes Infect. 2023 Dec;12(2):2239945 [PMID: 37483082]
  5. Vaccine. 2016 Nov 21;34(48):5819-5826 [PMID: 27780629]
  6. J Int Med Res. 2022 Feb;50(2):3000605221078782 [PMID: 35225710]
  7. Zhonghua Yi Xue Za Zhi. 2024 Apr 16;104(15):1258-1279 [PMID: 38637166]
  8. Int J Infect Dis. 2023 Mar;128:205-211 [PMID: 36632892]
  9. Nat Commun. 2022 Jul 1;13(1):3807 [PMID: 35778384]
  10. Clin Microbiol Infect. 2013 Jun;19(6):E260-2 [PMID: 23480481]
  11. World J Pediatr. 2020 Apr;16(2):185-192 [PMID: 31493136]
  12. Nucleic Acids Res. 2015 Sep 18;43(16):7762-8 [PMID: 26250111]
  13. Emerg Infect Dis. 2023 Jan;30(1):29-38 [PMID: 38146984]
  14. PLoS One. 2013 Oct 04;8(10):e77165 [PMID: 24124606]
  15. Zhongguo Dang Dai Er Ke Za Zhi. 2019 Mar;21(3):208-213 [PMID: 30907341]
  16. PLoS One. 2015 Sep 25;10(9):e0138941 [PMID: 26406905]
  17. Mol Biol Evol. 2020 May 1;37(5):1530-1534 [PMID: 32011700]
  18. Hum Vaccin Immunother. 2015;11(2):421-7 [PMID: 25610957]
  19. Vaccine. 2015 Nov 17;33(46):6277-81 [PMID: 26432908]
  20. J Clin Microbiol. 2003 Mar;41(3):1167-72 [PMID: 12624047]
  21. Adv Exp Med Biol. 2019;1183:19-33 [PMID: 31342459]
  22. Nucleic Acids Res. 2023 Jul 5;51(W1):W587-W592 [PMID: 37144476]
  23. Emerg Microbes Infect. 2019;8(1):461-470 [PMID: 30898080]
  24. Pathog Dis. 2015 Nov;73(8):ftv064 [PMID: 26297914]
  25. Int J Antimicrob Agents. 2001;18 Suppl 1:S25-8 [PMID: 11574191]
  26. Zhonghua Liu Xing Bing Xue Za Zhi. 2024 Feb 10;45(2):213-219 [PMID: 38413059]
  27. Emerg Infect Dis. 2019 Nov;25(11):2048-2054 [PMID: 31625838]
  28. Wellcome Open Res. 2018 Sep 24;3:124 [PMID: 30345391]
  29. Sci Transl Med. 2022 Apr 27;14(642):eabn3253 [PMID: 35476597]
  30. J Clin Microbiol. 2018 Apr 25;56(5): [PMID: 29491017]

Word Cloud

Created with Highcharts 10.0.0BPisolatespertussisChinaantimicrobialstrainsimmunizationsusceptibilitychildrensequencetypingidentifiedresistanceglobalHebeiinfectionMASTChinesegroupstwovaccineerythromycin-resistantMGT262typesshowedmayBackground:PertussishighlycontagiousrespiratorydiseasecausedDespitecontrolcasesExpandedProgrammeImmunizationEPIsignificantincreaseincidencerecentyearscharacterized"resurgence"developedcountrieshighrateswellcomparablereemergencecertainareasaimexploregenotypescirculatingStudydesign:Childrendiagnosed20192020enrolledperformedtestingASTwhole-genomesequencingWGSanalysissinglenucleotidepolymorphismSNPdetectionmltilocusMLSTmultilocusantigenmultilevelgenomeMGTtotal313internationalgenomesselectedcomparisonexaminegenomicdiversityevolutionarytraitswithinframeworkResults:Sixty-twoindividualsviacultureyieldingpositiverate1562%62/397TwophylogeneticcarryingdominatinggenotypeCSTohamaexhibiteddistantrelationshipstudy5655azithromycin-resistant58sulfamethoxazole-sensitive53cefotaxime-sensitivesensitivelevofloxacinamoxicillinceftriaxonemeropenemMeanwhilebelongedlineagetype7ST7sharedgenecontained23SrRNAA2047Gmutationmajor////7581%divided1231452MGT1MGT3MGT4MGT5levelsrespectivelyConclusion:worklinkalterationsspecificmolecularclearchangecomparedstrainselectionpressureantibioticsresponsibledrivingevolutionnecessitatereevaluationstrategydevelopmentnovelvaccineshaltresurgencemedicationMolecularcharacterizationBordetellaerythromycinptxP1

Similar Articles

Cited By

No available data.